dexmedetomidine has been researched along with Bone Loss, Perimenopausal in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, X; Liang, Y; Shi, H; Wang, Y; Wang, Z; Zhao, T | 1 |
1 other study(ies) available for dexmedetomidine and Bone Loss, Perimenopausal
| Article | Year |
|---|---|
Mechanism of dexmedetomidine regulating osteogenesis-angiogenesis coupling through the miR-361-5p/VEGFA axis in postmenopausal osteoporosis.
Topics: Aged; Animals; Bone Density; Dexmedetomidine; Female; Flow Cytometry; Humans; MicroRNAs; Middle Aged; Neovascularization, Physiologic; Oligonucleotide Array Sequence Analysis; Osteogenesis; Osteoporosis, Postmenopausal; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Vascular Endothelial Growth Factor A | 2021 |